JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
13 * ! | Sun, 7/29/2012, 2:00 PM - 3:50 PM | HQ-Sapphire MN | |
Increasing Clinical Program Success with Modeling and Simulation — Topic Contributed Papers | |||
Biopharmaceutical Section | |||
Organizer(s): Olga V Marchenko, Quintiles, Inc. | |||
Chair(s): Olga V Marchenko, Quintiles, Inc. | |||
2:05 PM | Improving Clinical Study Design and Understanding via Modeling and Simulation — Chyi-Hung Hsu, Janssen Pharmaceuticals, Inc. ; Jose Carlos Pinheiro, Johnson & Johnson ; Fei Chen, Janssen Pharmaceuticals, Inc. | ||
2:25 PM | Benefits of Model-Based Drug Development: A Rigorous Case Study — Russell Reeve, Quintiles, Inc. | ||
2:45 PM | Utilizing Modeling and Simulation to Optimize Phase 2 for Decisionmaking — Brenda Gaydos, Eli Lilly and Company | ||
3:05 PM | Improving Oncology Clinical Program by Use of Innovative Designs and Comparing via Simulations — Joel Miller, Eli Lilly and Company/ImClone ; Tom Parke, Tessella Inc. ; Donald Berry, MD Anderson Cancer Center ; Olga V Marchenko, Quintiles, Inc. ; Inna Perevozskaya, Pfizer Inc. ; Yanping Wang, Eli Lilly and Company | ||
3:25 PM | Discussant: Martin Kimber, Tessella Inc. | ||
3:45 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.